Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Autosomal recessive spondylocostal dysostosis (ARSD) is a rare condition of variable severity associated with vertebral and rib segmentation defects and characterized by a short neck with limited mobility, winged scapulae, a short trunk, and short stature with multiple vertebral anomalies at all levels of the spine.
No HPO annotations are available for this condition.
Age of onset: before birth, at birth.
Spondylocostal dysostosis (SCDO), defined radiographically as multiple segmentation defects of the vertebrae that is usually generalized throughout the spine, is characterized clinically by a short trunk in proportion to height, short neck, and non-progressive mild scoliosis in most affected individuals. To date, nearly 100 individuals have been identified and/or reported with SCDO and biallelic pathogenic variants in one of the genes listed in . The following description of the phenotypic features associated with this condition is based on the cited reports. Skeletal. Multiple segmentation defects of the vertebrae, which is usually generalized throughout the spine, results in:
Spondylocostal dysostosis (SCDO) should be suspected in individuals with the following radiographic features and family history:
Multiple segmentation defects of the vertebrae (M-SDV) most evident on anteroposterior radiograph of the whole spine. Abnormal segmentation of at least ten contiguous vertebrae. In the affected fetus or young child each vertebra is round or ovoid with smooth boundaries; the appearance of the vertebral column has been referred to as the "pebble beach" sign , especially in DLL3-related SCDO. As ossification proceeds after mid- to late childhood, the "pebble beach" appearance gives way to multiple irregularly shaped vertebral bodies and hemivertebrae that may be difficult to distinguish individually on plain x-ray.
No approved treatments are currently available for autosomal recessive spondylocostal dysostosis. The disease remains an area of unmet medical need.
No clinical practice guidelines for autosomal recessive spondylocostal dysostosis (SCDO) have been published. Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with autosomal recessive SCDO, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 3. Autosomal Recessive Spondylocostal Dysostosis: Recommended Evaluations Following Initial Diagnosis
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended. Table 5. Autosomal Recessive Spondylocostal Dysostosis: Recommended Surveillance
No clinical trials have been registered for autosomal recessive spondylocostal dysostosis.
16 publications have been identified in PubMed for autosomal recessive spondylocostal dysostosis. Research spans Case Report / Case Series (63%), Basic Science / Preclinical (19%), and Other (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 10 | 63% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 2:41 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Source: GeneReviews — "Spondylocostal Dysostosis, Autosomal Recessive"
Mild
scoliosis
Source: GeneReviews — "Spondylocostal Dysostosis, Autosomal Recessive"
Rarely, spondylocostal dysostosis (SCDO) occurs in association with chromosome abnormalities; however, apart from trisomy 8 mosaicism, no consistent genomic region has been involved, and the significance of these associations is unknown. Autosomal dominant SCDO. One family with autosomal dominant SCDO due to a heterozygous TBX6 pathogenic variant has been reported (OMIM 122600). Additional families with autosomal dominant SCDO without an identified gene have also been reported; in these families the extent of segmentation defects of the vertebrae is quite variable [, , , ]. Spondylothoracic dysostosis (STD), despite similarities to autosomal recessive SCDO, has distinctive phenotypic features that warrant this separate designation.
Source: GeneReviews — "Spondylocostal Dysostosis, Autosomal Recessive"
System/Concern | Evaluation | Comment |
|---|---|---|
Skeletal | Full spine x-rays, AP lateral x-rays, chest x-rays | — |
Respiratory | Assessment of respiratory function per pulmonologist, esp if tachypnea /or feeding difficulties suggest possibility of respiratory insufficiency | Gastrointestinal |
Urinary tract | Ultrasound eval of kidneys urinary tract | In persons w/LFNG-related SCDO Neurologic |
Genetic counseling | By genetics professionals1 | To inform affected persons their families re nature, MOI, implications of AR SCDO to facilitate medical personal decision making Family support resources |
Autosomal Recessive Spondylocostal Dysostosis: Treatment of Manifestations Manifestation/Concern | Treatment | Considerations/Other |
Growth | No specific nutritional needs to be considered other than maintaining appropriate weight for height | Persons w/SCDO all have variable short-trunk short stature. |
Scoliosis | Surgical intervention as needed if scoliosis is significant; severe scoliosis is unusual. | External bracing (e.g., using vertical expandable prosthetic titanium rib)1 may be considered, as well as growing rods other devices as appropriate. Respiratory distress/failure |
Neurologic | Standard treatment of neurologic problems assoc w/LFNG-related SCDO according to findings symptoms | Inguinal hernia |
Autosomal Recessive Spondylocostal Dysostosis: Recommended Surveillance System/Concern | Evaluation | Frequency |
Growth/Nutrition | Assess growth. | At each visit throughout childhood |
Skeletal | Assessment for spinal curvature | Annually or as needed Respiratory |
Neurologic | Assessment of neurologic motor function | Annually or as needed in those w/LFNG-related SCDO |
Development | Developmental assessment | Annually or as needed |
Gastrointestinal | The parents/care providers of young males need to be alert for signs of inguinal hernia its potential complications. | Annually or as needed SCDO = spondylocostal dysostosis Evaluation of Relatives at Risk See for issues related to testing of at-risk relatives for genetic counseling purposes. Virtually all individuals with SCDO have relative truncal shortening, and some have generalized short stature. |
Source: GeneReviews — "Spondylocostal Dysostosis, Autosomal Recessive"
View trials for autosomal recessive spondylocostal dysostosis
Evaluation |
|---|
Frequency |
|---|
Growth/Nutrition | Assess growth. | At each visit throughout childhood |
Skeletal | Assessment for spinal curvature | Annually or as needed Respiratory |
Neurologic | Assessment of neurologic motor function | Annually or as needed in those w/LFNG-related SCDO |
Development | Developmental assessment | Annually or as needed |
Gastrointestinal | The parents/care providers of young males need to be alert for signs of inguinal hernia its potential complications. | Annually or as needed SCDO = spondylocostal dysostosis |
Source: GeneReviews — "Spondylocostal Dysostosis, Autosomal Recessive"
Estimated prevalence: Unknown (Unknown prevalence).
Laboratory research
3 |
19% |
Other research | 2 | 13% |
Research summaries | 1 | 6% |
Varney S (2026). [PMID: 41751515](https://pubmed.ncbi.nlm.nih.gov/41751515/). *Genes (Basel)*. [Basic Science / Preclinical]
Darouich S (2026). [PMID: 41527833](https://pubmed.ncbi.nlm.nih.gov/41527833/). *Pediatr Dev Pathol*. [Case Report / Case Series]
Rips J (2026). [PMID: 41014130](https://pubmed.ncbi.nlm.nih.gov/41014130/). *Am J Med Genet A*. [Case Report / Case Series]
Shan H (2025). [PMID: 39836964](https://pubmed.ncbi.nlm.nih.gov/39836964/). *Am J Respir Crit Care Med*. [Other]
Atitallah S (2025). [PMID: 40538613](https://pubmed.ncbi.nlm.nih.gov/40538613/). *Ochsner J*. [Case Report / Case Series]
De Jesús-Rojas W (2025). [PMID: 39836966](https://pubmed.ncbi.nlm.nih.gov/39836966/). *Am J Respir Crit Care Med*. [Other]
Dghoughi B (2025). [PMID: 40165844](https://pubmed.ncbi.nlm.nih.gov/40165844/). *Radiol Case Rep*. [Case Report / Case Series]
Song E (2025). [PMID: 40188016](https://pubmed.ncbi.nlm.nih.gov/40188016/). *BMC Anesthesiol*. [Case Report / Case Series]
Ramírez-Rodríguez Á (2025). [PMID: 40964570](https://pubmed.ncbi.nlm.nih.gov/40964570/). *Cureus*. [Case Report / Case Series]
Abera MT (2024). [PMID: 38860271](https://pubmed.ncbi.nlm.nih.gov/38860271/). *Radiol Case Rep*. [Case Report / Case Series]